---
title: "Medtronic wins FDA clearance for Affera Prism-2 cardiac mapping software"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/300577791.md"
description: "Medtronic has received FDA clearance and CE Mark for its Affera Prism-2 Mapping Software, designed to assist in cardiac ablation procedures. Additionally, the CE Mark was granted for the PulseSelect ProxBox Adapter with Proximity Indicator software, which provides real-time tissue proximity feedback during surgeries."
datetime: "2026-09-30T13:06:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/300577791.md)
  - [en](https://longbridge.com/en/news/300577791.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/300577791.md)
generator: "portal-rs"
---

# Medtronic wins FDA clearance for Affera Prism-2 cardiac mapping software

-   Medtronic won FDA clearance and CE Mark for its Affera Prism-2 Mapping Software for use in cardiac ablation procedures. \* CE Mark also granted for the PulseSelect ProxBox Adapter with Proximity Indicator software, adding real-time tissue proximity feedback. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medtronic plc published the original content used to generate this news brief via PR Newswire (Ref. ID: CG59974) on September 30, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

### Related Stocks

- [MDT.US](https://longbridge.com/en/quote/MDT.US.md)

## Related News & Research

- [Medtronic wins FDA clearance for ApexCut EM navigated sinus surgery blades](https://longbridge.com/en/news/301143168.md)
- [Medtronic Announces Final Exchange Ratio of 4.5939 in Split-Off of MiniMed Group, Inc. | MDT Stock News](https://longbridge.com/en/news/301188933.md)
- [Medtronic PLC Stock (MDT) Moved Up by 3.36% on Oct 12: Key Drivers Unveiled](https://longbridge.com/en/news/301609124.md)
- [Medtronic reports 88.1% ulcer healing rate at 24 months in VenaSeal venous leg ulcer study](https://longbridge.com/en/news/300864845.md)
- [How Investors Are Reacting To Medtronic (MDT) Cardiac Ablation Surge And Near-Dividend-King Milestone](https://longbridge.com/en/news/296452586.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**